These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Krasnewich DM; Holt GD; Brantly M; Skovby F; Redwine J; Gahl WA Glycobiology; 1995 Jul; 5(5):503-10. PubMed ID: 8563136 [TBL] [Abstract][Full Text] [Related]
3. Enzymes involved in the synthesis of mannose-6-phosphate from glucose are normal in carbohydrate deficient glycoprotein syndrome fibroblasts. Panneerselvam K; Freeze HH Biochem Biophys Res Commun; 1995 Mar; 208(2):517-22. PubMed ID: 7695602 [TBL] [Abstract][Full Text] [Related]
4. Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1. Panneerselvam K; Etchison JR; Skovby F; Freeze HH Biochem Mol Med; 1997 Aug; 61(2):161-7. PubMed ID: 9259981 [TBL] [Abstract][Full Text] [Related]
5. A partial deficiency of dehydrodolichol reduction is a cause of carbohydrate-deficient glycoprotein syndrome type I. Ohkura T; Fukushima K; Kurisaki A; Sagami H; Ogura K; Ohno K; Hara-Kuge S; Yamashita K J Biol Chem; 1997 Mar; 272(11):6868-75. PubMed ID: 9054372 [TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-deficient glycoprotein syndrome: not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis? Powell LD; Paneerselvam K; Vij R; Diaz S; Manzi A; Buist N; Freeze H; Varki A J Clin Invest; 1994 Nov; 94(5):1901-9. PubMed ID: 7962535 [TBL] [Abstract][Full Text] [Related]
7. Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose. Körner C; Lehle L; von Figura K Glycoconj J; 1998 May; 15(5):499-505. PubMed ID: 9881752 [TBL] [Abstract][Full Text] [Related]
8. Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency. Körner C; Lehle L; von Figura K Glycobiology; 1998 Feb; 8(2):165-71. PubMed ID: 9451026 [TBL] [Abstract][Full Text] [Related]
9. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. Burda P; Borsig L; de Rijk-van Andel J; Wevers R; Jaeken J; Carchon H; Berger EG; Aebi M J Clin Invest; 1998 Aug; 102(4):647-52. PubMed ID: 9710431 [TBL] [Abstract][Full Text] [Related]
10. Alteration of mannose transport in fibroblasts from type I carbohydrate deficient glycoprotein syndrome patients. Dupre T; Ogier-Denis E; Moore SE; Cormier-Daire V; Dehoux M; Durand G; Seta N; Codogno P Biochim Biophys Acta; 1999 Mar; 1453(3):369-77. PubMed ID: 10101255 [TBL] [Abstract][Full Text] [Related]
11. Analysis of glycosylation in CDG-Ia fibroblasts by fluorophore-assisted carbohydrate electrophoresis: implications for extracellular glucose and intracellular mannose 6-phosphate. Gao N; Shang J; Lehrman MA J Biol Chem; 2005 May; 280(18):17901-9. PubMed ID: 15708848 [TBL] [Abstract][Full Text] [Related]
12. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts. Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417 [TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase. Körner C; Knauer R; Holzbach U; Hanefeld F; Lehle L; von Figura K Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13200-5. PubMed ID: 9789065 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity. Freeze HH; Aebi M Biochim Biophys Acta; 1999 Oct; 1455(2-3):167-78. PubMed ID: 10571010 [TBL] [Abstract][Full Text] [Related]
15. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602 [TBL] [Abstract][Full Text] [Related]
16. Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts. Higashidani A; Bode L; Nishikawa A; Freeze HH Mol Genet Metab; 2009 Apr; 96(4):268-72. PubMed ID: 19157945 [TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-deficient glycoprotein syndromes: inborn errors of protein glycosylation. Keir G; Winchester BG; Clayton P Ann Clin Biochem; 1999 Jan; 36 ( Pt 1)():20-36. PubMed ID: 10370757 [TBL] [Abstract][Full Text] [Related]
19. Transfer of two oligosaccharides to protein in a Chinese hamster ovary cell B211 which utilizes polyprenol for its N-linked glycosylation intermediates. Kaiden A; Rosenwald AG; Cacan R; Verbert A; Krag SS Arch Biochem Biophys; 1998 Oct; 358(2):303-12. PubMed ID: 9784244 [TBL] [Abstract][Full Text] [Related]
20. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Alton G; Kjaergaard S; Etchison JR; Skovby F; Freeze HH Biochem Mol Med; 1997 Apr; 60(2):127-33. PubMed ID: 9169093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]